BR112014030680A2 - forma de dosagem efervescente - Google Patents
forma de dosagem efervescenteInfo
- Publication number
- BR112014030680A2 BR112014030680A2 BR112014030680A BR112014030680A BR112014030680A2 BR 112014030680 A2 BR112014030680 A2 BR 112014030680A2 BR 112014030680 A BR112014030680 A BR 112014030680A BR 112014030680 A BR112014030680 A BR 112014030680A BR 112014030680 A2 BR112014030680 A2 BR 112014030680A2
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- effervescent
- effervescent dosage
- agent
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/2036—Silicones; Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
Abstract
1/1 resumo "forma de dosagem efervescente" a presente invenção refere-se a uma forma de dosagem efervescente mastigável que compreende um agente de neutralização de ph, um ácido, e um agente efervescente. a forma de dosagem mastigável pode também compreender adicionalmente simeticona, um adoçante, e um lubrificante. o agente de neutralização de ph pode ser carbonato de cálcio, o ácido pode ser ácido cítrico e o agente efervescente pode ser bicarbonato de sódio.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261658430P | 2012-06-12 | 2012-06-12 | |
US61/658,430 | 2012-06-12 | ||
PCT/US2013/045303 WO2013188483A1 (en) | 2012-06-12 | 2013-06-12 | Effervescent dosage form |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014030680A2 true BR112014030680A2 (pt) | 2017-06-27 |
BR112014030680B1 BR112014030680B1 (pt) | 2022-08-30 |
Family
ID=48672843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014030680-0A BR112014030680B1 (pt) | 2012-06-12 | 2013-06-12 | Forma de dosagem mastigável efervescente |
Country Status (12)
Country | Link |
---|---|
US (1) | US10617714B2 (pt) |
EP (1) | EP2734192B1 (pt) |
CN (1) | CN104363897A (pt) |
AU (1) | AU2013274378B2 (pt) |
BR (1) | BR112014030680B1 (pt) |
CA (1) | CA2876062C (pt) |
ES (1) | ES2541723T3 (pt) |
IN (1) | IN2014DN10385A (pt) |
MX (1) | MX368363B (pt) |
PL (1) | PL2734192T3 (pt) |
RU (1) | RU2014149581A (pt) |
WO (1) | WO2013188483A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2604124A1 (en) * | 2011-12-16 | 2013-06-19 | Nestec S.A. | Soluble non-dairy creamer tablet surface-treated with carbohydrate |
CA2990162A1 (en) * | 2015-06-29 | 2017-01-05 | Elc Management Llc | Particles with cross-linked coatings for cosmetic applications |
CN107114795A (zh) * | 2017-07-06 | 2017-09-01 | 胥永贵 | 一种弱碱补钙、苏打碱化姜制剂及其制备方法和应用 |
US11793876B2 (en) | 2019-10-18 | 2023-10-24 | L. Perrigo Company | Bulk polyethylene glycol compositions |
WO2022060310A1 (en) * | 2020-09-18 | 2022-03-24 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Pharmaceutical compositions comprising calcium carbonate, magnesium carbonat and simethicone |
EP4355114A1 (en) * | 2021-06-17 | 2024-04-24 | Ocean Spray Cranberries, Inc. | Rare sugars in food and beverage products |
US12053484B2 (en) | 2021-10-29 | 2024-08-06 | Medicated Chews, Llc | Simethicone chewable composition |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1518364A (en) | 1976-05-05 | 1978-07-19 | Beecham Group Ltd | Pharmaceutical composition |
US4198390A (en) | 1979-01-31 | 1980-04-15 | Rider Joseph A | Simethicone antacid tablet |
US4396604A (en) | 1982-05-17 | 1983-08-02 | Norcliff Thayer, Inc. | Simethicone antacid lozenge |
US4678661A (en) * | 1983-09-28 | 1987-07-07 | Gerhard Gergely | Effervescent composition and method of making same |
JPS6092378A (ja) | 1983-09-28 | 1985-05-23 | ゲルハルト・ゲルゲリー | 起泡剤およびその製造方法 |
US4650669A (en) | 1985-07-30 | 1987-03-17 | Miles Laboratories, Inc. | Method to make effervescent calcium tablets and calcium tablets produced thereby |
GB8909793D0 (en) | 1989-04-28 | 1989-06-14 | Beecham Group Plc | Pharmaceutical formulation |
US5073384A (en) | 1989-10-19 | 1991-12-17 | Valentine Enterprises, Inc. | Maltodextrin/defoaming composition combinate |
DE59203732D1 (de) | 1991-07-01 | 1995-10-26 | Gergely Gerhard | Lutsch- oder Kautablette. |
AU4597293A (en) | 1992-06-30 | 1994-01-24 | Procter & Gamble Company, The | Effervescent calcium supplements |
US5330760A (en) * | 1992-08-27 | 1994-07-19 | Sterling Winthrop Inc. | Effervescent antacid |
FR2705966B1 (fr) | 1993-06-04 | 1995-08-25 | Dow Corning Sa | Compositions antimousse utiles notamment pour le traitement de troubles gastriques. |
ES2142601T3 (es) | 1995-07-31 | 2000-04-16 | Gerhard Gergely | Comprimido masticable con accion efervescente. |
CN1167436A (zh) | 1995-09-07 | 1997-12-10 | 大制药株式会社 | 低压泡滕片剂 |
US5807577A (en) | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5888544A (en) | 1996-06-20 | 1999-03-30 | Gerhard Gergely | Effervescent system for effervescent tablets and effervescent granules |
DE19814256A1 (de) | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
GB9825033D0 (en) | 1998-11-13 | 1999-01-13 | Nycomed Pharma As | Process |
US6296868B1 (en) | 1998-11-19 | 2001-10-02 | Advanced Technology Pharmaceuticals Corporation | Chewable tablets containing mannitol and aspartame |
DE19859231A1 (de) | 1998-12-21 | 2000-06-29 | Kurt Heinz Bauer | Schäumende Antacida-Suspensionstabletten |
US6589555B2 (en) | 1999-12-29 | 2003-07-08 | Mahendra Pandya | Effervescent vitaceutical compositions and related methods |
US6544557B2 (en) | 2001-01-09 | 2003-04-08 | Pan Pharmaceutical Limited | Effervescent tablet compositions |
US20030235613A1 (en) | 2002-06-19 | 2003-12-25 | Cts Chemical Industries Ltd. | Popping oral administration form |
US20040223921A1 (en) | 2003-05-07 | 2004-11-11 | Rau Allen H. | Oral care tablet |
US20050074489A1 (en) | 2003-10-01 | 2005-04-07 | Pediamed Pharmaceuticals, Inc. | Effervescent and effervescent-dispersion compositions for medicaments and methods of use thereof |
ITMI20040242U1 (it) | 2004-05-24 | 2004-08-24 | Istituto Pirri S R L | Contenitore per compresse effervescenti |
ES2390781T3 (es) | 2004-10-13 | 2012-11-16 | Kraft Foods Global Brands Llc | Composiciones de comprimidos masticables efervescentes |
US20090004248A1 (en) | 2007-06-29 | 2009-01-01 | Frank Bunick | Dual portion dosage lozenge form |
EP2189154A1 (en) | 2008-11-25 | 2010-05-26 | Gnosis S.p.A. | Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof |
CN101966165B (zh) | 2009-07-14 | 2012-06-13 | 无锡健而乐医药科技有限公司 | 口腔吸收固体泡腾制剂 |
WO2011113965A1 (es) | 2010-03-18 | 2011-09-22 | Farmalider, S.A. | Composición farmacéutica en forma sólida que contiene isoflavonas, una sal de calcio y vitamina d3 |
CN102232967A (zh) * | 2010-04-21 | 2011-11-09 | 武汉同济现代医药有限公司 | 一种新型口服补钙泡腾剂及其制备方法 |
US20140371174A1 (en) | 2013-06-12 | 2014-12-18 | The Procter & Gamble Company | Effervescent Dosage Form |
-
2013
- 2013-06-12 RU RU2014149581A patent/RU2014149581A/ru unknown
- 2013-06-12 WO PCT/US2013/045303 patent/WO2013188483A1/en active Application Filing
- 2013-06-12 CA CA2876062A patent/CA2876062C/en active Active
- 2013-06-12 AU AU2013274378A patent/AU2013274378B2/en active Active
- 2013-06-12 IN IN10385DEN2014 patent/IN2014DN10385A/en unknown
- 2013-06-12 CN CN201380031083.4A patent/CN104363897A/zh active Pending
- 2013-06-12 PL PL13731013T patent/PL2734192T3/pl unknown
- 2013-06-12 EP EP13731013.2A patent/EP2734192B1/en active Active
- 2013-06-12 MX MX2014015253A patent/MX368363B/es active IP Right Grant
- 2013-06-12 ES ES13731013.2T patent/ES2541723T3/es active Active
- 2013-06-12 BR BR112014030680-0A patent/BR112014030680B1/pt active IP Right Grant
-
2019
- 2019-05-09 US US16/407,268 patent/US10617714B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2541723T3 (es) | 2015-07-24 |
EP2734192A1 (en) | 2014-05-28 |
AU2013274378A1 (en) | 2015-01-15 |
RU2014149581A (ru) | 2016-07-10 |
CN104363897A (zh) | 2015-02-18 |
MX2014015253A (es) | 2015-03-05 |
US10617714B2 (en) | 2020-04-14 |
CA2876062A1 (en) | 2013-12-19 |
PL2734192T3 (pl) | 2015-09-30 |
AU2013274378B2 (en) | 2016-06-02 |
MX368363B (es) | 2019-09-30 |
WO2013188483A1 (en) | 2013-12-19 |
CA2876062C (en) | 2017-09-12 |
BR112014030680B1 (pt) | 2022-08-30 |
IN2014DN10385A (pt) | 2015-08-14 |
EP2734192B1 (en) | 2015-04-15 |
US20190262392A1 (en) | 2019-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014030680A2 (pt) | forma de dosagem efervescente | |
AR100925A1 (es) | Composiciones orales que contienen fuentes de ión de zinc, estaño y fluoruro | |
BR112014004460A2 (pt) | material polimérico para um recipiente isolado | |
BR112018075140A2 (pt) | composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8 | |
BR112014004444A2 (pt) | composições e métodos que compreendem uma variante de enzima lipolítica | |
AR092957A1 (es) | Formulacion de forma farmaceutica solida de desintegracion veloz que comprende carbonato de calcio funcionalizado y metodo para su fabricacion | |
AR084285A1 (es) | Composiciones inmunogenicas | |
PE20191796A1 (es) | Composicion farmaceutica de clorhidrato de s-ketamina | |
CL2014003503A1 (es) | Composición farmacéutica para uso intramamario que comprende un ácido fosfónico y al menos un agente antimicrobiano; y uso para el tratamiento o prevención de mastitis en mamífero no humano. | |
PE20161498A1 (es) | Composicion reactiva basada en bicarbonato de sodio y procedimiento para su produccion | |
WO2014153009A3 (en) | Thiosaccharide mucolytic agents | |
EA201600442A1 (ru) | Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол | |
BR112015027477A2 (pt) | método para tratamento de um transtorno de deglutição | |
BR112013011259A2 (pt) | condições de tratamento associadas com nível aumentado de eotaxina com 25-hidroxivitamina d3 | |
WO2014107730A3 (en) | Use of fatty acid niacin conjugates for treating diseases | |
BR112013030068A2 (pt) | grânulos de controle biológico estabilizados dispersíveis em água | |
BR112015017465A2 (pt) | composição de óleo para prevenção de ferrugem | |
NZ609742A (en) | Aqueous solution of ambroxol | |
EA201690854A1 (ru) | Фармацевтические композиции с гидратирующим и смазывающим действием | |
AR100454A1 (es) | Composiciones dentífricas que mitigan la placa dental o tienen mejor captación de fluoruro | |
AR070593A1 (es) | Composiciones efervescentes | |
EA201992382A2 (ru) | Пероральная таблетированная фармацевтическая композиция двойного применения на основе сульфатных солей и способы ее применения | |
EA201170101A1 (ru) | Фармацевтические композиции роувастатина кальция | |
AR087371A1 (es) | Formulaciones de (trimetoxifenilamino)pirimidinilo, metodos | |
BR112013033060A2 (pt) | solução oftálmica contendo ácido hialurônico ou sal deste e propileno glicol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/06/2013, OBSERVADAS AS CONDICOES LEGAIS |